首页> 美国卫生研究院文献>Frontiers in Pharmacology >Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro
【2h】

Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro

机译:当归补血汤单独及与他莫昔芬或雷洛昔芬联用时的体内外骨骼保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Danggui Buxue Tang (DBT), a traditional Chinese Medicine decoction containing Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), is commonly prescribed for women in China as a remedy for menopausal symptoms. Previous study indicated that DBT stimulated cell growth and differentiation of human osteosarcoma MG-63 cells and exhibited estrogenic properties via estrogen receptors (ERs). The present study aimed to study the bone protective effects of DBT and its potential interactions with selective estrogen receptor modulators (SERMs, tamoxifen and raloxifene) in both in vivo and in vitro models as they act via similar ERs. Six-month-old Sprague-Dawley rats were randomly assigned to the following treatments for 12 weeks: (1) sham-operated control group with vehicle (sham), (2) ovariectomized group with vehicle (OVX), (3) OVX with 17β-estradiol (E2, 2.0 mg/kg day), (4) OVX with tamoxifen (Tamo, 1.0 mg/kg day), (5) OVX with raloxifene (Ralo, 3.0 mg/kg day), (6) OVX with DBT (DBT, 3.0 g/kg day), (7) OVX with DBT+Tamoxifen (DBT+Tamo), and (8) OVX with DBT+Raloxifene (DBT+Ralo). Effects of DBT and potential interactions between DBT and SERMs were also evaluated in MG-63 cells. DBT, tamoxifen, raloxifene, and their combinations significantly increased bone mineral density (BMD) and improved trabecular bone properties, including bone surface (BS), trabecular bone number (Tb.N), and trabecular bone separation (Tb.Sp), as well as restored changes in bone turnover biomarkers and mRNA expression of genes involved in bone metabolism in OVX rats. Furthermore, DBT, SERMs, and their combinations significantly increased serum estradiol and suppressed follicle stimulating hormone and luteinizing hormone in OVX rats, suggesting the possible involvement of the hypothalamus–pituitary–gonadal axis in mediating their bone protective effects. However, SERMs, but not DBT, significantly increased uterus index in OVX rats. DBT significantly induced ALP activity and estrogen response element-dependent transcription in MG-63 cells. Our study demonstrated that DBT alone and in combinations with SERMs could exert bone protective effects in vitro and in vivo.
机译:当归补血汤(DBT)是一种含有黄芪(当归)和当归(ASR)的中药汤剂,在中国女性中通常被认为是治疗更年期症状的药物。先前的研究表明,DBT刺激人骨肉瘤MG-63细胞的生长和分化,并通过雌激素受体(ER)表现出雌激素特性。本研究旨在研究DBT的骨保护作用及其与选择性雌激素受体调节剂(SERM,他莫昔芬和雷洛昔芬)在体内和体外模型中的潜在相互作用,因为它们通过相似的ER起作用。将6个月大的Sprague-Dawley大鼠随机分配至以下治疗组,为期12周:(1)假手术对照组和赋形剂(sham),(2)卵巢切除组的赋形剂(OVX),(3)OVX赋形剂17β-雌二醇(E2,2.0 mg / kg天),(4)OVX与他莫昔芬(Tamo,1.0 mg / kg天),(5)OVX与雷洛昔芬(Ralo,3.0 mg / kg天),(6)OVX与DBT(DBT,3.0 g / kg日),(7)含DBT +他莫昔芬(DBT + Tamo)的OVX,和(8)含DBT +雷洛昔芬(DBT + Ralo)的OVX。在MG-63细胞中也评估了DBT的作用以及DBT和SERM之间潜在的相互作用。 DBT,他莫昔芬,雷洛昔芬及其组合显着提高了骨矿物质密度(BMD),并改善了小梁的骨骼特性,包括骨表面(BS),小梁骨数(Tb.N)和小梁骨分离(Tb.Sp),以及恢复了OVX大鼠骨骼代谢相关生物标志物和涉及骨骼代谢的基因的mRNA表达的变化。此外,DBT,SERM及其组合可显着增加OVX大鼠的血清雌二醇,并抑制卵泡刺激素和促黄体生成激素,表明下丘脑-垂体-性腺轴可能参与了其骨骼保护作用。但是,SERM而非DBT显着增加了OVX大鼠的子宫指数。 DBT在MG-63细胞中显着诱导ALP活性和雌激素反应元件依赖性转录。我们的研究表明,单独使用DBT或与SERMs联合使用可在体内和体外发挥骨骼保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号